Technical Analysis for BLCO - Bausch + Lomb Corporation
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
20 DMA Resistance | Bearish | 3.19% | |
Volume Surge | Other | 3.19% | |
Gapped Up | Strength | 3.19% | |
New 52 Week Closing Low | Bearish | 9.56% | |
180 Bearish Setup | Bearish Swing Setup | 9.56% | |
Slingshot Bearish | Bearish Swing Setup | 9.56% |
Alert | Time |
---|---|
Gap Up Partially Closed | about 19 hours ago |
1.5x Volume Pace | about 19 hours ago |
Gapped Up (Partial) | about 19 hours ago |
Rose Above 20 DMA | about 19 hours ago |
Rose Above Previous Day's High | about 19 hours ago |
Get a Trading Assistant
- Earnings date: 05/14/2024
Bausch + Lomb Corporation Description
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Ophthalmology Glaucoma Vision Cataracts Surgical Specialties Treatment Of Glaucoma Contact Lenses Cataract Surgery Conjunctivitis Lens Care Products Ocular Hypertension Retinal Diseases Generic Pharmaceutical Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 21.95 |
52 Week Low | 13.16 |
Average Volume | 486,006 |
200-Day Moving Average | 16.31 |
50-Day Moving Average | 15.66 |
20-Day Moving Average | 14.53 |
10-Day Moving Average | 14.47 |
Average True Range | 0.63 |
RSI (14) | 50.00 |
ADX | 24.9 |
+DI | 21.39 |
-DI | 25.62 |
Chandelier Exit (Long, 3 ATRs) | 14.67 |
Chandelier Exit (Short, 3 ATRs) | 15.04 |
Upper Bollinger Bands | 15.50 |
Lower Bollinger Band | 13.56 |
Percent B (%b) | 0.69 |
BandWidth | 13.36 |
MACD Line | -0.38 |
MACD Signal Line | -0.41 |
MACD Histogram | 0.0301 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 15.73 | ||||
Resistance 3 (R3) | 15.70 | 15.39 | 15.59 | ||
Resistance 2 (R2) | 15.39 | 15.18 | 15.41 | 15.54 | |
Resistance 1 (R1) | 15.15 | 15.05 | 15.27 | 15.18 | 15.50 |
Pivot Point | 14.84 | 14.84 | 14.91 | 14.86 | 14.84 |
Support 1 (S1) | 14.60 | 14.63 | 14.72 | 14.63 | 14.30 |
Support 2 (S2) | 14.29 | 14.50 | 14.31 | 14.26 | |
Support 3 (S3) | 14.05 | 14.29 | 14.21 | ||
Support 4 (S4) | 14.08 |